First Hit the Best Hit for Advanced Differentiated Papillary Thyroid Carcinoma?

Area of Science:

• Oncology
• Surgical Oncology
• Nuclear Medicine

Background:

• Differentiated thyroid cancer (DTC) treatment traditionally involves surgery and radioiodine therapy.
• Post-operative radioiodine therapy aims to ablate remnant thyroid tissue and treat potential metastases.
• Minimizing adjuvant therapies like radioiodine is desirable to reduce side effects and long-term risks.

Purpose of the Study:

• To evaluate the role of upfront surgery with precise image mapping in optimizing DTC treatment outcomes.
• To explore the potential of reducing or avoiding post-operative radioiodine therapy.
• To assess the feasibility of surgical intervention for advanced or inoperable DTC using modern therapeutic approaches.

Main Methods:

• Utilizing precise and objective image mapping techniques for surgical planning and execution.
• Applying targeted agents and principles of precision medicine in the management of DTC.
• Performing upfront surgical resection in patients with advanced or inoperable DTC.

Main Results:

• Precise image-guided surgery enhances treatment outcomes in DTC.
• Upfront surgical approaches can potentially mitigate the necessity for post-operative radioiodine therapy.
• Advances enable surgical treatment for previously inoperable advanced DTC.

Conclusions:

• Optimal upfront surgery with precise image mapping is a promising strategy for DTC.
• This approach may reduce reliance on post-operative radioiodine therapy.
• Precision medicine facilitates surgical options for advanced DTC, improving patient management.